New apalutamide study opens for prostate cancer

February 14, 2018

A new phase 3 study at Providence Cancer Institute will compare the effectiveness of three different treatment regimens in men with biochemically recurrent prostate cancer:

Experimental arm: apalutamide, an investigational, next-generation oral androgen receptor (AR) inhibitor, plus degarelix, a hormonal therapy used to reduce testosterone
Experimental arm: apalutamide and degarelix plus abiraterone acetate and prednisone
Control arm: degarelix alone

“Apalutamide (ARN-509) reduced the risk of metastasis or death by 72% in patients with nonmetastatic castration-resistant prostate cancer,” according to findings from the phase 3 SPARTAN trial reported in OncLive on Feb. 5. The SPARTAN trial, published in the New England Journal of Medicine on Feb. 8, found that “median metastasis-free survival was more than 2 years longer” for men who received apalutamide. Read more in the New York Times.

Brendan Curti, M.D., the principal investigator of the new three-arm study at Providence Cancer Institute, is a medical oncologist and director of genitourinary oncology research at the Earle A. Chiles Research Institute.

See Providence study details here:

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

More prostate cancer studies

This study is one of three clinical trials open to men with prostate cancer at Providence Cancer Institute. See all prostate cancer studies.

To refer patients to any of these studies, call Providence Cancer Institute’s Clinical Research office at 503-215-2614 or visit oregon.providence.org/clinical-trials.

Welcome to your journey for creating a healthier you

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

Most Recent Articles

We are very pleased to announce that Providence Holy Cross Medical Center has been nationally recognized as an approved Pancreatic Cancer Center of Excellence by the National Pancreas Foundation (NPF)

Providence Alaska Medical Center has once again been recognized as the top health care provider in Alaska in the U.S. News & World Report 2020-21 Best Hospitals honor roll and specialty rankings.

Load up on your veggies with this avocado and bean hummus dip. This Mediterranean-style appetizer is the perfect choice as an appetizer that is ready in minutes.

A zucchini slaw is a refreshing and unique twist for this Mexican, seafood entrée fish taco recipe, which packs a wallop of flavor while also hitting all the healthy criteria.

Providence Little Company of Mary's partnership with City of Hope helps a patient reduce his commute and spend more time doing what he loves.

Providence St. Joseph Hospital in Eureka recently received designation renewal for its Level III Trauma Center

In this Live event, Providence leaders discuss COVID and the rollout of the vaccine en Espanol.

A phase II, investigator-initiated clinical trial at Providence Cancer Institute aims to improve survival for patients with triple-negative breast cancer. The trial is available only at Providence.

There is an undeniable part of human nature that makes us feel like we must tackle big challenges by ourselves. Why are we often hesitant to reach out for help when we are struggling the most?

Cardiac care team at the Providence Heart Institute at St. Joseph Hospital in Eureka hosted virtual community health forum

A world traveler who loved her hometown and Providence Little Company of Mary.

Providence's Glenda Fossum-Smith shares how one experience changed her view of the homelessness pandemic.

While visiting your loved ones, we ask you to respectfully comply with our visitor policy

We asked Anton J. Bilchik, MD, PhD, director of our gastrointestinal and hepatobiliary program at Providence Saint John’s, to explain why timely colorectal cancer screening is important.

While visiting your loved ones, we ask you to respectfully comply with our visitor policy

The Recovery Center at Providence Little Company of Mary Medical Center San Pedro plans to reach even more people seeking treatment for alcohol or drug abuse.

Providence Heart Beat is your source for program news and service updates within the Providence Health Care family. Read the spring 2021 issue now.

Providence Little Company of Mary Medical Center San Pedro expands many service lines to meet the needs of the community.

While visiting your loved ones, we ask you to respectfully comply with our visitor policy

We understand the importance of patients having access to their loved ones while receiving care at Providence hospitals. To protect the health of our patients and caregivers, and as a safety precautio